Trimetazidine added to combined hemodynamic antianginal therapy in patients with type 2 diabetes: a randomized crossover trial
To access this article, please choose from the options below
Dr Ribeiro reports having received consulting and lecture fees and grant support from Laboratórios Servier do Brasil.
PII: S0002-8703(07)00347-X
doi:10.1016/j.ahj.2007.04.026
© 2007 Mosby, Inc. All rights reserved.
